ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
437 hedge funds and large institutions have $21.8B invested in Alexion Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 148 increasing their positions, 181 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
18% less repeat investments, than reductions
Existing positions increased: 148 | Existing positions reduced: 181
Holders
437
Holding in Top 10
6
Calls
$249M
Puts
$162M
Top Buyers
| 1 | +$367M | |
| 2 | +$153M | |
| 3 | +$127M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$91.8M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$90.2M |
Top Sellers
| 1 | -$243M | |
| 2 | -$165M | |
| 3 | -$162M | |
| 4 |
Jennison Associates
New York
|
-$119M |
| 5 |
Sands Capital Management
Arlington,
Virginia
|
-$103M |